ROIV · Forms 3, 4, 5
Insider trades at Roivant Sciences Ltd.
2 insiders sold $8M of Roivant Sciences Ltd. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Roivant Sciences Ltd. (ROIV) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Director | Returned to company | 8,967,383 | $5.00 | $44.8M | Form 4 | |
| Epperly Melissa B, | Director | Option exercise | 17,750 | $4.46 | $79K | Form 4 | |
| Epperly Melissa B, | Director | Sell | 16,850 | $36.08 | $608K | Form 4 | |
| Epperly Melissa B, | Director | Sell | 900 | $36.57 | $33K | Form 4 | |
| Matthew Gline | CEO | Tax withholding | 76,171 | $36.57 | $2.8M | Form 4 | |
| Frank Torti | President and Vant Chair | Tax withholding | 40,309 | $36.57 | $1.5M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Tax withholding | 46,879 | $36.57 | $1.7M | Form 4 | |
| Eric Venker | President & Immunovant CEO | Option exercise | 200,000 | $3.85 | $770K | Form 4 | |
| Eric Venker | President & Immunovant CEO | Sell | 200,000 | $36.62 | $7.3M | Form 4 | |
| Jennifer Humes | Chief Accounting Officer | Tax withholding | 3,880 | $39.77 | $154K | Form 4 | |
| Richard Pulik | CFO | Tax withholding | 2,129 | $39.77 | $85K | Form 4 | |
| Keith S Manchester | Director | Award | 5,054 | Form 4 | |||
| Daniel Allen Gold | Director | Award | 5,054 | Form 4 | |||
| Ilan Oren | Director | Award | 5,054 | Form 4 | |||
| James C Momtazee | Director | Award | 5,054 | Form 4 | |||
| Meghan Fitzgerald | Director | Award | 5,054 | Form 4 | |||
| Epperly Melissa B, | Director | Award | 5,054 | Form 4 | |||
| Epperly Melissa B, | Director | Sell | 4,338 | $39.65 | $172K | Form 4 | |
| Epperly Melissa B, | Director | Sell | 600 | $40.38 | $24K | Form 4 | |
| Meghan Fitzgerald | Director | Sell | 4,712 | $39.68 | $187K | Form 4 | |
| Meghan Fitzgerald | Director | Sell | 400 | $40.45 | $16K | Form 4 | |
| Daniel Allen Gold | Director | Tax withholding | 5,133 | $40.94 | $210K | Form 4 | |
| Ilan Oren | Director | Tax withholding | 2,378 | $40.94 | $97K | Form 4 | |
| Epperly Melissa B, | Director | Tax withholding | 2,179 | $40.94 | $89K | Form 4 | |
| Meghan Fitzgerald | Director | Tax withholding | 1,743 | $40.94 | $71K | Form 4 | |
| James C Momtazee | Director | Tax withholding | 2,905 | $40.94 | $119K | Form 4 | |
| Meghan Fitzgerald | Director | Option exercise | 20,000 | $8.80 | $176K | Form 4 | |
| Meghan Fitzgerald | Director | Sell | 20,000 | $39.90 | $798K | Form 4 | |
| Eric Venker | President & Immunovant CEO | Option exercise | 200,000 | $3.85 | $770K | Form 4 | |
| Eric Venker | President & Immunovant CEO | Sell | 166,182 | $35.63 | $5.9M | Form 4 | |
| Eric Venker | President & Immunovant CEO | Sell | 33,818 | $36.44 | $1.2M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 144,756 | $3.85 | $557K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 144,756 | $36.48 | $5.3M | Form 4 | |
| Richard Pulik | CFO | Tax withholding | 5,749 | $36.84 | $212K | Form 4 | |
| Eric Venker | President & Immunovant CEO | Tax withholding | 13,909 | $36.84 | $512K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 17,519 | $3.85 | $67K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 17,519 | $37.30 | $653K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 172,899 | $3.85 | $666K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 172,899 | $37.17 | $6.4M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 105,141 | $3.85 | $405K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 105,141 | $36.59 | $3.8M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 31,801 | $3.85 | $122K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 31,801 | $37.18 | $1.2M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 284,707 | $3.85 | $1.1M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 284,707 | $36.25 | $10.3M | Form 4 | |
| Mayukh Sukhatme | President & CIO | Option exercise | 243,177 | $3.85 | $936K | Form 4 | |
| Mayukh Sukhatme | President & CIO | Sell | 243,177 | $36.23 | $8.8M | Form 4 | |
| Eric Venker | President & Immunovant CEO | Option exercise | 200,000 | $3.85 | $770K | Form 4 | |
| Eric Venker | President & Immunovant CEO | Sell | 200,000 | $34.95 | $7M | Form 4 | |
| James C Momtazee | Director | Award | 405 | Form 4 | |||
| Epperly Melissa B, | Director | Award | 543 | Form 4 | |||
| Ilan Oren | Director | Award | 775 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.